200 related articles for article (PubMed ID: 26823568)
1. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
[TBL] [Abstract][Full Text] [Related]
2. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
[TBL] [Abstract][Full Text] [Related]
3. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
4. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization with
Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
7. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
Willowson KP; Bailey EA; Bailey DL
Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
[TBL] [Abstract][Full Text] [Related]
8. Patient-specific radiation dose for Chinese pediatric patients undergoing whole-body PET/CT examinations.
Jia H; Xue M; Li X; Zhuang M; Xie T
Phys Med Biol; 2024 Jun; 69(12):. PubMed ID: 38776955
[No Abstract] [Full Text] [Related]
9. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
[TBL] [Abstract][Full Text] [Related]
10. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
11. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
[TBL] [Abstract][Full Text] [Related]
12. Radiation Dosimetry of a Novel Adenosine A
Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
[TBL] [Abstract][Full Text] [Related]
13. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
[TBL] [Abstract][Full Text] [Related]
15. A new upper limit for effective dose in patient administered with 18F-FDG for PET/CT whole-body imaging with diagnostic CT parameters.
Velo P; Ismail MI; Mohandas KK; Kasilingam L
J Med Imaging Radiat Sci; 2023 Mar; 54(1):43-50. PubMed ID: 36402716
[TBL] [Abstract][Full Text] [Related]
16. Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
Vardhanabhuti V; Lo AW; Lee EY; Law SY
Clin Nucl Med; 2016 Nov; 41(11):864-865. PubMed ID: 27648704
[TBL] [Abstract][Full Text] [Related]
17. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
19. PET-Based Human Dosimetry of
Boss M; Buitinga M; Jansen TJP; Brom M; Visser EP; Gotthardt M
J Nucl Med; 2020 Jan; 61(1):112-116. PubMed ID: 31519801
[No Abstract] [Full Text] [Related]
20. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.
Huang B; Law MW; Khong PL
Radiology; 2009 Apr; 251(1):166-74. PubMed ID: 19251940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]